We completed the relative quantification of the light chain of system xc-, xCT, in surgical grade IV GBM samples varying in their isocitrate dehydrogenase (IDH) mutational status, compared to grade II-III glioma samples (Table S1), and brain tissue obtained from autopsy. Here, IDH2 is linked to central nervous system cancer.